As of 2025-07-06, the Intrinsic Value of Nattopharma ASA (NATTO.OL) is 44.30 NOK. This NATTO.OL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 34.80 NOK, the upside of Nattopharma ASA is 27.30%.
The range of the Intrinsic Value is 33.17 - 70.23 NOK
Based on its market price of 34.80 NOK and our intrinsic valuation, Nattopharma ASA (NATTO.OL) is undervalued by 27.30%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 33.17 - 70.23 | 44.30 | 27.3% |
DCF (Growth 10y) | 37.11 - 73.90 | 48.24 | 38.6% |
DCF (EBITDA 5y) | 22.67 - 30.85 | 26.62 | -23.5% |
DCF (EBITDA 10y) | 28.09 - 37.42 | 32.47 | -6.7% |
Fair Value | 11.81 - 11.81 | 11.81 | -66.06% |
P/E | 26.61 - 56.66 | 38.30 | 10.1% |
EV/EBITDA | 10.97 - 26.79 | 18.58 | -46.6% |
EPV | 14.78 - 18.52 | 16.65 | -52.1% |
DDM - Stable | 38.06 - 114.62 | 76.34 | 119.4% |
DDM - Multi | 25.89 - 60.79 | 36.34 | 4.4% |
Market Cap (mil) | 690.43 |
Beta | 1.22 |
Outstanding shares (mil) | 19.84 |
Enterprise Value (mil) | 662.09 |
Market risk premium | 4.74% |
Cost of Equity | 6.54% |
Cost of Debt | 5.00% |
WACC | 6.48% |